Guangdong Association Of Clinical Trials

We track 2 ClinicalTrials.gov studies led by Guangdong Association Of Clinical Trials. The portfolio skews toward Phase 4 (1 trials).

2 clinical trials sponsored by Guangdong Association Of Clinical Trials.

Pipeline by Phase

PhaseTrialsDistribution
Phase 4 1
50%
Phase 2 1
50%

Trial Status Breakdown

Trials by Guangdong Association Of Clinical Trials

An Open-label, Single-arm, Multicenter, Prospective Study of Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases

NCT06282874 · ACTIVE NOT RECRUITING · Phase 4

Evaluation of Safety and Efficacy of Serplulimab Plus Chemotherapy in Patients With Histological Transformation From EGFR-mutated NSCLC to SCLC After Treatment: a Single-arm, Multicenter, Open-label Phase II Study

NCT05957510 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Guangdong Association Of Clinical Trials sponsor?

Guangdong Association Of Clinical Trials currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 4, Phase 2.

What conditions does Guangdong Association Of Clinical Trials research?

Guangdong Association Of Clinical Trials conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Guangdong Association Of Clinical Trials recruiting for clinical trials?

Yes, Guangdong Association Of Clinical Trials currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More